MOBILE DNA TESTING - AN OVERVIEW

Each time I've requested pharmacogenomic testing, I have noticed a clinically substantial variant in the gene that may influence my treatment decisions. In a significant research populace, the rate of clinically major variants in at the very least a single test was more than 90%.Other than 23andMe—which mixes ancestry mapping with overall health